Urokinase expression in course of benign and malignant mammary lesions: comparison between nodular and healthy tissues

J Cancer Res Clin Oncol. 2010 Jan;136(1):157-63. doi: 10.1007/s00432-009-0694-1. Epub 2009 Oct 14.

Abstract

Purpose: Increased expression of urokinase (uPA), a member of the serine protease family, is an effector of metastatic cascade and has been reported in various malignancies, including breast cancer. uPA overexpression in cancer tissues was correlated with a more aggressive phenotype and it is considered a strong and independent unfavorable prognostic factor in breast cancer.

Methods: Using real-time PCR assay, we analyzed uPA expression of malignant and benign breast nodular lesions versus healthy tissues (normal breast and lymphocytes).

Results: We found that besides breast cancer nodule, normal mammary gland and lymphocytes overexpressed uPA too. Tissues obtained from women with benign lesions expressed homogeneous and lower uPA.

Conclusions: In conclusion, although uPA overexpression is typical of cancer tissues, it could be considered as a feature of the whole organism affected by cancer. On the basis of these first results, uPA could be considered for further studies as a possible useful therapeutic target in breast cancer.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Breast / metabolism
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / pathology
  • Female
  • Gene Expression Profiling*
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Lymphocytes / metabolism
  • Middle Aged
  • Receptor, ErbB-2 / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Urokinase-Type Plasminogen Activator / genetics*

Substances

  • Receptor, ErbB-2
  • Urokinase-Type Plasminogen Activator